VIR
USDVir Biotechnology Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$5.460
Максимум
$5.520
Минимум
$5.200
Объем
1.66M
Фундаментальные показатели компании
Рыночная капитализация
729.3M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.44M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
Vir Biotechnology, Inc. (NASDAQ:VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025. The Company will
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer
– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical trial builds on
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD's The Liver Meeting® 2025
– Week 48 endpoint results from the SOLSTICE Phase 2 clinical study evaluating tobevibart alone or in combination with elebsiran for chronic hepatitis delta to be presented – Vir Biotechnology to showcase progress in
Связанные акции
DGICA
Donegal Group Inc.
IGR
CBRE Global Real Estate Income Fund Common Shares of Beneficial Interest
TRMK
Trustmark Corporation
CRL
Charles River Laboratories International Inc.
WHLR
Wheeler Real Estate Investment Trust Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.